Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): ARP110101028
Who filed: Fundación Grupo Efecto Positivo
Country: Argentina
Opposition type: Pre-Grant
Opposition status: Refused
Date: 20-12-2021
Patent type: Molecules

Click within the document, or manually enter the page number below

Fundación Grupo Efecto Positivo opposition, Remdesivir (GS-5734), (AR102468)

Countries: Argentina Date: 2021
Fundación Grupo Efecto Positivo opposition, Lenacapavir, (AR109364A1)

Countries: Argentina Date: 2022
Fundación Grupo Efecto Positivo opposition, Tenofovir Alafenamide Fumarate , (P2012103681 (AR088109A1) )

Countries: Argentina Date: 2020
Fundación Grupo Efecto Positivo opposition, Lenacapavir, (AR118856 )

Countries: Argentina Date: 2022
Fundación Grupo Efecto Positivo opposition, Islatravir , (AR107596 (WO2017/139519) )

Countries: Argentina Date: 2020
Fundación Grupo Efecto Positivo opposition, Tenofovir 300mg+ Emtricitabina 200mg (TDF+FTC), (n/a)

Countries: Argentina Date: 2015
Fundación Grupo Efecto Positivo opposition, Sofosbuvir, (WO/2008/121634)

Countries: Argentina Date: 2015
Fundación Grupo Efecto Positivo opposition, Remdesivir, (WO2016069826 (A1))

Countries: Argentina Date: 2020
Fundación Grupo Efecto Positivo opposition, Molnupiravir (MK-4482), (AR12285A1)

Countries: Argentina Date: 2022
Fundación Grupo Efecto Positivo opposition, Sofosbuvir/Velpatasvir, (AR 095133 Al (P140100355))

Countries: Argentina Date: 2018

Fundación Grupo Efecto Positivo Opposition, Doravirine (Nnrti), (Arp110101028)